Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age

Hyperbilirubinaemia is one of the most frequent problems in otherwise healthy newborn infants. Early discharge of the healthy newborn infants, particularly those in whom breastfeeding is not fully established, may be associated with delayed diagnosis of significant hyperbilirubinaemia that has the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Romagnoli, Costantino, Barone, Giovanni, Pratesi, Simone, Raimondi, Francesco, Capasso, Letizia, Zecca, Enrico, Dani, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015911/
https://www.ncbi.nlm.nih.gov/pubmed/24485088
http://dx.doi.org/10.1186/1824-7288-40-11
_version_ 1782315426204614656
author Romagnoli, Costantino
Barone, Giovanni
Pratesi, Simone
Raimondi, Francesco
Capasso, Letizia
Zecca, Enrico
Dani, Carlo
author_facet Romagnoli, Costantino
Barone, Giovanni
Pratesi, Simone
Raimondi, Francesco
Capasso, Letizia
Zecca, Enrico
Dani, Carlo
author_sort Romagnoli, Costantino
collection PubMed
description Hyperbilirubinaemia is one of the most frequent problems in otherwise healthy newborn infants. Early discharge of the healthy newborn infants, particularly those in whom breastfeeding is not fully established, may be associated with delayed diagnosis of significant hyperbilirubinaemia that has the potential for causing severe neurological impairments. We present the shared Italian guidelines for management and treatment of jaundice established by the Task Force on hyperbilirubinaemia of the Italian Society of Neonatology. The overall aim of the present guidelines is to provide an useful tool for neonatologists and family paediatricians for managing hyperbilirubinaemia.
format Online
Article
Text
id pubmed-4015911
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40159112014-05-10 Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age Romagnoli, Costantino Barone, Giovanni Pratesi, Simone Raimondi, Francesco Capasso, Letizia Zecca, Enrico Dani, Carlo Ital J Pediatr Research Hyperbilirubinaemia is one of the most frequent problems in otherwise healthy newborn infants. Early discharge of the healthy newborn infants, particularly those in whom breastfeeding is not fully established, may be associated with delayed diagnosis of significant hyperbilirubinaemia that has the potential for causing severe neurological impairments. We present the shared Italian guidelines for management and treatment of jaundice established by the Task Force on hyperbilirubinaemia of the Italian Society of Neonatology. The overall aim of the present guidelines is to provide an useful tool for neonatologists and family paediatricians for managing hyperbilirubinaemia. BioMed Central 2014-01-31 /pmc/articles/PMC4015911/ /pubmed/24485088 http://dx.doi.org/10.1186/1824-7288-40-11 Text en Copyright © 2014 Romagnoli et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Romagnoli, Costantino
Barone, Giovanni
Pratesi, Simone
Raimondi, Francesco
Capasso, Letizia
Zecca, Enrico
Dani, Carlo
Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
title Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
title_full Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
title_fullStr Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
title_full_unstemmed Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
title_short Italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
title_sort italian guidelines for management and treatment of hyperbilirubinaemia of newborn infants ≥ 35 weeks’ gestational age
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015911/
https://www.ncbi.nlm.nih.gov/pubmed/24485088
http://dx.doi.org/10.1186/1824-7288-40-11
work_keys_str_mv AT romagnolicostantino italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage
AT baronegiovanni italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage
AT pratesisimone italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage
AT raimondifrancesco italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage
AT capassoletizia italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage
AT zeccaenrico italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage
AT danicarlo italianguidelinesformanagementandtreatmentofhyperbilirubinaemiaofnewborninfants35weeksgestationalage

Ejemplares similares